Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Summary

Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy obtaining sustained virologic response (SVR) in 77% of naïve patients with genotype 1-3 Studies rarely address the issues of improving host factors. The current study examines whether adding vitamin D with Peg/RBV, a potent immunomodulator, could improve viral response(SVR)compared to Peg/RBV.

Timeline

Start

2011-09

Primary completion

2017-12-15

Completion

2018-01-20

Drugs

Indications